CD44 variant isoforms are involved in plasma cell adhesion to bone marrow stromal cells

Leukemia

Volumn 16, Issue 1, 2002, Pages 135-143

  Van Driel, M ^d   Gunhert U ^b   van Kessel, A C ^a   Joling, P ^a   Stauder, R ^c   Lokhorst, H M ^a   Bloem, A C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Adhesion; CD44 variant molecules; CD44v; Multiple myeloma; Stromal cells

Indexed keywords

CD44V ANTIGEN; CD44V6 ANTIGEN; CD44V9 ANTIGEN; HYALURONIC ACID; INTERLEUKIN 6; ISOPROTEIN; REAGENT; UNCLASSIFIED DRUG;

ARTICLE; BINDING ASSAY; BONE MARROW; CELL ADHESION; CELL GROWTH; CELL INTERACTION; CELL LINE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE RELEASE; DISEASE COURSE; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STROMA CELL;

EID: 85009834509     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402336     Document Type: Article

References (62)

1. Multiple myeloma: Increasing evidence for a multistep transformation process
2. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19)
3. Characterization of adhesion molecules on human myeloma cell lines
4. Lymphocyte function-associated antigen-1 expression on plasma cells correlates with tumor growth in multiple myeloma
5. Heterogeneous expression of a novel MPC-1 antigen on myeloma cells: Possible involvement of the MPC-1 antigen in the adhesion of mature myeloma cells to bone marrow stromal cells
6. Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen
7. Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures
8. Adhesion molecules on human myeloma cells: Significant changes in expression related to malignancy, tumor spreading, and immortalization
9. Expression of CD21 antigen on myeloma cells and its involvement in their adhesion to bone marrow stromal cells
10. Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: Alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44
11. The 86-kD subunit of Ku autoantigen mediates homotypic and heterotypic adhesion of multiple myeloma cells
12. Adhesion of human myeloma derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion
13. Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin
14. Interleukin-6 is the central tumour growth factor in vitro and in vivo in multiple myeloma
15. CD44: A multitude of isoforms with diverse functions
16. Different CD44 splicing patterns define prognostic subgroups in multiple myeloma
17. CD44 isoforms distinguish between bone marrow plasma cells from normal individuals and patients with multiple myeloma at different stages of disease
18. CD44 and its interaction with extracellular matrix
19. Requirement for CD44 in activated T cell extravasation into an inflammatory site
20. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures
21. CD44 isoforms - Impact on lymphocyte activation and differentiation
22. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells
23. Adhesive and/or signaling functions of CD44 isoforms in human dendritic cells
24. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function
25. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
26. CD44 variant isoforms in non-Hodgkin’s lymphoma: A new independent prognostic factor
27. A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia
28. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression
29. CD44 is the principal cell surface receptor for hyaluronate
30. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin
31. Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells
32. CD44 participates in the adhesion of human colorectal carcinoma cells to laminin and type IV collagen
33. Receptor-ligand interaction between CD44 and osteopontin (Eta-1)
34. A novel ligand for CD44 is serglycin a hematopoietic cell lineage-specific proteoglycan - Possible involvement in lymphoid cell adherence and activation
35. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44
36. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival
37. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies
38. Long-term bone marrow cultured stromal cells regulate myeloma tumour growth in vitro: Studies with primary tumour cells and LTBMC-dependent cell lines
39. The establishment of an interleukin-6 dependent myeloma cell line (FLAM-76) carrying t(11;14)(q13;q32) chromosome abnormality from an aggressive nonsecretory plasma cell leukemia
40. Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma
41. Expression and modulation of CD44 variant isoforms in humans
42. Cutting edge: Curative treatment of an experimentally induced colitis by a CD44 variant v7-specific antibody
43. A family of cell-surface glycoproteins defined by a putative anti-endothelial cell receptor antibody in man
44. A novel flow cytometric assay for the quantification of adhesion of subsets within a heterogeneous cell population; Analysis of lymphocyte function-associated antigen-1 (LFA-1)-mediated binding of bone cells of patients with multiple myeloma
45. Anti-adhesive signals are mediated via major histocompatibility complex class II molecules in normal and neoplastic human B cells: Correlation with B cell differentiation
46. Platelet adhesion to exposed endothelial cell extracellular matrixes is influenced by the method of preparation
47. Cultured endothelial cells regulate platelet adhesion to their extracellular matrix by regulating its von Willebrand factor content
48. Comparison of platelet interaction of subendothelium of human renal and umbilical arteries and the extracellular matrix produced by human venous endothelial cells
49. Re-examination and further development of a precize and rapid dye method for measuring cell growth/cell kill
50. Assessment of cell binding to hyaluronic acid in a solid-phase assay
51. CD44: Structure, function, and association with the malignant process
52. CD44 structure and function
53. Identification of hyaluronic acid binding sites in the extracellular domain of CD44
54. Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type
55. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan
56. Keratan sulfate modification of CD44 modulates adhesion to hyaluronate
57. TNF-alpha induction of CD44-mediated leukocyte adhesion by sulphation
58. Adhesive interactions between alternatively spliced CD44 isoforms
59. Alternatively spliced CD44 isoforms containing exon v10 promote cellular adhesion through the recognition of chondroitin sulfate-modified CD44
60. Regulation of growth and dissemination of a human lymphoma by CD44 splice variants
61. Production of cytokines by bone marrow stromal cells obtained from patients with multiple myeloma
62. Cytokines involved in the progression of multiple myeloma